Symbiotec Pharmalab share news, announcements
NSE: SYMBIOTECBSE: 544889Pharmaceuticals & Biotechnology
Share price at the NSE close on 30 Oct 2026. Previous close ₹1,250.20.
30 Oct: open ₹1,250.00, high ₹1,267.50, low ₹1,217.00
- Next results date: the board meets on 5 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. Market capitalisation: how it is worked out
- ₹8,008 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- No full year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- No balance sheet
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonesince listing in Sep 2026
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 2,70,33435.1% delivered
Symbiotec Pharmalab has 15 announcements on record, routine notices left out; 3 in the 30 days to 30 Oct 2026, the latest on 28 Oct 2026.
Next board meeting and results date
As the company gave notice to the exchange.Symbiotec Pharmalab quarterly results
The board meets on 5 Nov 2026 to consider financial results
Notice filed 28 Oct 2026
Symbiotec Pharmalab annual reports, presentations and earnings calls
The company's own documents, latest first.
Investor presentations1
- Investor Presentation21 Sep 2026
Earnings calls2
- Transcript28 Sep 2026
- Link of Recording22 Sep 2026
Symbiotec Pharmalab share news and announcements
Newest first.
Oct 2026
28 Oct · Analysts
Sep 2026
30 Sep
21 Sep · Board meeting
21 Sep · Results
11 Sep · Board meeting
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts). Delivery against usual in the glossary
- 22 Sep 2026Resultsdown 3.04%−2.8 pts vs Nifty 500market median −0.7% · five sessions −8.7% (−5.9 pts vs Nifty 500) · delivery +0.8 pts against usual · The announcement
Symbiotec Pharmalab results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.